Literature DB >> 19823969

In vitro-in vivo correlation of modified release dosage form of lamotrigine.

Hiten J Shah1, Gunta Subbaiah, Dasharath M Patel, Chhagan N Patel.   

Abstract

The plasma concentration profile of lamotrigine was predicted from the dissolution test data of the modified release 100 mg lamotrigine tablet by applying the in vitro-in vivo correlation (IVIVC). Three different release formulations (L-1, L-2 and L-3) and its profiles of in vitro data were generated in different dissolution media. Pharmacokinetics evaluation of these formulations was carried out in 12 healthy volunteers. In vitro-in vivo correlation was established from the generated dissolution and bioavailability data. A good correlation between the percentages dissolved vs absorbed (r2>0.989) was obtained using level A correlation. Evaluation of the internal predictability of level A correlation was calculated in terms of percent prediction error, which was found to be below 15%. Copyright 2009 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19823969     DOI: 10.1002/bdd.688

Source DB:  PubMed          Journal:  Biopharm Drug Dispos        ISSN: 0142-2782            Impact factor:   1.627


  5 in total

1.  Improvement of physicochemical properties of an antiepileptic drug by salt engineering.

Authors:  Ziyaur Rahman; Ahmed S Zidan; Raghu Samy; Vilayat A Sayeed; Mansoor A Khan
Journal:  AAPS PharmSciTech       Date:  2012-05-17       Impact factor: 3.246

2.  Comparison of dissolution profiles and serum concentrations of two lamotrigine tablet formulations.

Authors:  Mladena Lalic; Ana Pilipovic; Svetlana Golocorbin-Kon; Ksenija Gebauer-Bukurov; Ksenija Bozic; Momir Mikov; Jelena Cvejic
Journal:  Drugs R D       Date:  2011

3.  Use of the Biopharmaceutics Drug Disposition Classification System (BDDCS) to Help Predict the Occurrence of Idiosyncratic Cutaneous Adverse Drug Reactions Associated with Antiepileptic Drug Usage.

Authors:  Rosa Chan; Chun-Yu Wei; Yuan-Tsong Chen; Leslie Z Benet
Journal:  AAPS J       Date:  2016-03-07       Impact factor: 4.009

4.  Enhancement of Solubility of Lamotrigine by Solid Dispersion and Development of Orally Disintegrating Tablets Using 3(2) Full Factorial Design.

Authors:  Jatinderpal Singh; Rajeev Garg; Ghanshyam Das Gupta
Journal:  J Pharm (Cairo)       Date:  2015-10-27

5.  Formulation and evaluation of cyclodextrin-based nanosponges of griseofulvin as pediatric oral liquid dosage form for enhancing bioavailability and masking bitter taste.

Authors:  Samia M Omar; Fares Ibrahim; Aliaa Ismail
Journal:  Saudi Pharm J       Date:  2020-02-03       Impact factor: 4.330

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.